Fluphenazine decanoate and Diphen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fluphenazine decanoate (fluphenazine decanoate) and Diphen (diphenhydramine hydrochloride). Common drug interactions include thought insertion among females and electrocardiogram qt prolonged among males.

The phase IV clinical study analyzes what interactions people have when they take Fluphenazine decanoate and Diphen. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Fluphenazine decanoate?

Fluphenazine decanoate has active ingredients of fluphenazine decanoate. eHealthMe is studying from 599 Fluphenazine decanoate users. Check the latest studies of Fluphenazine decanoate.

What is Diphen?

Diphen has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 115,432 Diphen users. Check the latest studies of Diphen.



On Jul, 14, 2026

12 people who take Fluphenazine decanoate and Diphen together, and have interactions are studied.

Fluphenazine decanoate and Diphen drug interactions.

What are the common drug interactions of Fluphenazine Decanoate and Diphen, by gender? *:

female:

  1. Thought insertion (the idea that another thinks through the mind of the person)
  2. Transient psychosis (short term loss of contact with reality)
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Type 2 diabetes mellitus
  5. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  6. Vulvovaginal injury
  7. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  8. Psychotic disorder
  9. Agitation (state of anxiety or nervous excitement)
  10. Pyrexia (fever)

male:

  1. Electrocardiogram qt prolonged
  2. Blood prolactin increased
  3. Delirium (wild excitement)
  4. Drug abuse
  5. Fatigue (feeling of tiredness)
  6. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  7. Schizophreniform disorder (mental disorder is diagnosed when the symptom criteria for schizophrenia are met, but the duration is too short and social and occupational functioning)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  10. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

What are the common drug interactions of Fluphenazine Decanoate and Diphen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anxiety
  2. Bradykinesia (decreased bodily movement. it is associated with basal ganglia diseases)
  3. Coprolalia (uncontrolled, often obsessive use of obscene or scatological language)
  4. Decreased appetite
  5. Dyskinesia (abnormality or impairment of voluntary movement)
  6. Loss of consciousness
  7. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  8. Somnambulism (sleep walking)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups)

20-29:

n/a

30-39:

  1. Drug abuse
  2. Drug dependence
  3. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  4. Abasia (inability to walk)
  5. Agitation (state of anxiety or nervous excitement)
  6. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  7. Drug level increased
  8. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  9. Faecal incontinence (a lack of control over passing stool)
  10. Hallucination, auditory (perceiving sounds without auditory stimulus)

40-49:

  1. Aggression
  2. Agitation (state of anxiety or nervous excitement)
  3. Arrhythmia (irregular heartbeat)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Cardiac arrest
  6. Cough
  7. Drug ineffective
  8. Electrocardiogram qt prolonged
  9. Hypotension (abnormally low blood pressure)
  10. Loss of consciousness

50-59:

n/a

60+:

  1. Fatigue (feeling of tiredness)
  2. Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
  3. Anger
  4. Antisocial behaviour
  5. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
  6. Breast cancer
  7. Chest pain
  8. Constipation
  9. Cyclothymic disorder (mood disorder)
  10. Delusion (a false belief or opinion)

What are the existing conditions these people have? *

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 25.00%
  2. Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups): 2 people, 16.67%
  3. Stress And Anxiety: 2 people, 16.67%
  4. Gilles De La Tourette Syndrome (a condition that causes people to make repeated, quick movements or sounds that they cannot control): 2 people, 16.67%
  5. Weight Increased: 1 person, 8.33%
  6. Urinary Tract Infection: 1 person, 8.33%
  7. Schizoaffective Disorder Bipolar Type (mental illness featuring schizophrenia and a mood disorder with mania): 1 person, 8.33%
  8. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 8.33%
  9. Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 1 person, 8.33%
  10. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Fluphenazine decanoate and Diphen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fluphenazine decanoate and Diphen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fluphenazine decanoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Diphen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluphenazine decanoate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diphen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluphenazine decanoate and diphenhydramine hydrochloride (the active ingredients of Fluphenazine decanoate and Diphen, respectively), and Fluphenazine decanoate and Diphen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: